Lu AF82422 is often a mAb proven as safe and effectively tolerated in a period I demo in healthier topics and people with PD (NCT03611569). A stage II examine investigating the basic safety and efficacy in people with https://orlandowmjw518248.targetblogs.com/30768940/getting-my-parkinson-s-vs-multiple-system-atrophy-to-work